Albumedix Ltd. (‘Albumedix’), the world leader in recombinant human albumin (rAlb), announced today its succession plan as Peter Rosholm, after 13 years leading the company, has decided to step down as CEO and handover the company’s leadership. Peter’ successor as Chief Executive Officer is his long-standing colleague, and the Company’s Chief Operating...
Promethean Particles re-starts production
Medilink EM Member Company Promethean Particles has resumed manufacturing at its site today following the implementation of new safety measures to reduce the risk from Covid-19. The company’s Nottingham site is home to the world’s largest multi-material nanomaterial plant of its kind. In March, it closed its doors in line...
Mental Health Support during the Pandemic
We are currently and will be for some time yet, living and working in strange times which brings new challenges and stress to our daily lives. This is something that most of us will never have experienced in our lifetime. Thankfully times are changing and people are generally opening up...
COVID-19 vaccine trial opens in Nottingham
Trial of new vaccine for COVID-19 From today, doctors from Cripps Health Centre on the University of Nottingham campus, are offering front-line healthcare staff the chance to take part in the first nationwide trial of a vaccine for COVID-19. Supported by the research teams at Nottingham University Hospitals (NUH) and the...
PHARMASEAL are offering Engility CTMS at no cost to support Phase II clinical trials in return for BETA testing
Engility® trial management platform developed by PHARMASEAL provides a solution to overcome many traditional challenges in clinical trial management. With centralised data on all clinical trials encompassing clinical trial management processes including study management, flexible monitoring, issue management, investigator payments, site and contract management and now including integrated eTMF document...
Coronavirus: Private company rises to ‘exceptional challenge’ to double antigen testing
Medilink EM Patron Company Source BioScience said what they have achieved in five weeks would normally take between six months to a year. Source BioScience is one of a small number of private companies processing antigen tests for the government, letting NHS staff and patients know if they have COVID-19....
Digital innovation within the NHS – a necessity, not a nice to have
In a keynote address earlier this year, Matt Hancock, the Secretary of State for Health and Social Care, spoke about better technology being a necessity, not a ‘nice to have’ saying “better technology is vital to have and embracing it is the only way to make the NHS sustainable over...
Innovate UK: Continuity Grants and Loans
On Friday 15th May 2020, Innovate UK released full details about their Continuity Grants and Loans – the COVID-19 support for Innovate UK’s Existing Grant Recipients. Here are the main points and where you can find more information! Continuity Grants Innovate UK have allocated up to £90 million in continuity...
Locate Bio announces the appointment of John von Benecke as CEO
Medilink EM Member Locate Bio Ltd, an orthobiologics company pursuing multiple high-value spinal opportunities, today announces that John von Benecke has been appointed CEO to drive Locate’s lead program for spinal fusion and continue to build out its spinal pipeline. John von Benecke has served as COO/CFO for Locate since...
Footfalls & Heartbeats joins Advanced Wellbeing Research Centre accelerator
Footfalls & Heartbeats, a Nottingham-based intelligent textiles business, will access state-of-the-art laboratories, business support packages and specialist facilities to help bring its products to market and improve people’s quality of life. Based at Sheffield Hallam’s new world-leading £14m research centre, start-up businesses on the programme have access to world-class research...
